| Status: | Phase 3 |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| HIV Infections; HIV Seropositivity | Phase 1 | ClinicalTrials |
| HIV Infections | Phase 1 | ClinicalTrials |
| Encephalomyelitis; Fatigue; Fatigue Syndrome, Chronic; Myalgia; Syndrome | Phase 3 | ClinicalTrials |
| Fallopian Tube Neoplasms; Peritoneal Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
CONTENTS